Erratum: Evidence Why Paroxetine Dose Escalation is Not Effective in Major Depressive Disorder: A Randomized Controlled Trial with Assessment of Serotonin Transporter Occupancy

被引：0
|
作者：
Henricus G Ruhé
Jan Booij
Henk C v Weert
Johannes B Reitsma
Eric JF Fransen
Martin C Michel
Aart H Schene
机构：
来源：
Neuropsychopharmacology | 2009年 / 34卷 / 4期
关键词：
D O I：
10.1038/npp.2008.213
中图分类号：
学科分类号：
摘要：
Correction to: Neuropsychopharmacology advance online publication, 1 October 2008; doi: 10.1038/npp.2008.148 In this article, published online on 1 October 2008, one author's name is spelled incorrectly; it should have appeared as Eric JF Franssen.
引用
收藏
页码：1088 / 1088
相关论文
共 50 条
  • [31] Personality disorder and functioning in major depressive disorder: a nested study within a randomized controlled trial
    Kavanagh, Bianca E.
    Williams, Lana J.
    Berk, Michael
    Turner, Alyna
    Jackson, Henry J.
    Mohebbi, Mohammadreza
    Kanchanatawan, Buranee
    Ashton, Melanie M.
    Ng, Chee H.
    Maes, Michael
    Berk, Lesley
    Malhi, Gin S.
    Dowling, Nathan
    Singh, Ajeet B.
    Dean, Olivia M.
    BRAZILIAN JOURNAL OF PSYCHIATRY, 2020, 42 (01) : 14 - 21
  • [32] The serotonin transporter (SERT) occupancy in median raphe nucleus quantified with PET predicts treatment response to SSRIs in major depressive disorder
    Akimova, E.
    Lanzenberger, R.
    Savli, M.
    Haeusler, D.
    Wadsak, W.
    Spindelegger, C.
    Moser, U.
    Fink, M.
    Kletter, K.
    Kasper, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S389 - S389
  • [33] Single-Dose Psilocybin Treatment for Major Depressive Disorder A Randomized Clinical Trial
    Raison, Charles L.
    Sanacora, Gerard
    Woolley, Joshua
    Heinzerling, Keith
    Dunlop, Boadie W.
    Brown, Randall T.
    Kakar, Rishi
    Hassman, Michael
    Trivedi, Rupal P.
    Robison, Reid
    Gukasyan, Natalie
    Nayak, Sandeep M.
    Hu, Xiaojue
    O'Donnell, Kelley C.
    Kelmendi, Benjamin
    Sloshower, Jordan
    Penn, Andrew D.
    Bradley, Ellen
    Kelly, Daniel F.
    Mletzko, Tanja
    Nicholas, Christopher R.
    Hutson, Paul R.
    Tarpley, Gary
    Utzinger, Malynn
    Lenoch, Kelsey
    Warchol, Kasia
    Gapasin, Theraysa
    Davis, Mike C.
    Nelson-Douthit, Courtney
    Wilson, Steffanie
    Brown, Carrie
    Linton, William
    Ross, Stephen
    Griffiths, Roland R.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (09): : 843 - 853
  • [34] Sini powder with paroxetine ameliorates major depressive disorder by modulating circadian rhythm: A randomized, double-blind, placebo-controlled trial
    He, Xu
    Zhang, Ruihuan
    Li, Zhe
    Yao, Zhen
    Xie, Xiaoxia
    Bai, Ruoxue
    Li, Lan
    Zhang, Xu
    Zhang, Sha
    Shen, Yan
    Li, Shaowei
    Hui, Zhenliang
    Liu, Rongrong
    Chen, Jun
    JOURNAL OF PINEAL RESEARCH, 2022, 73 (04)
  • [35] Clinical efficacy of tandospirone augmentation in patients with major depressive disorder: A randomized controlled trial
    Yamada, K
    Yagi, G
    Kanba, S
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2003, 57 (02) : 183 - 187
  • [36] Randomized controlled trial of transcranial magnetic stimulation in pregnant women with major depressive disorder
    Kim, Deborah R.
    Wang, Eileen
    McGeehan, Brendan
    Snell, Jessica
    Ewing, Grace
    Iannelli, Claudia
    O'Reardon, John P.
    Sammel, Mary D.
    Epperson, C. Neill
    BRAIN STIMULATION, 2019, 12 (01) : 96 - 102
  • [37] Open-Label Placebo for Major Depressive Disorder: A Pilot Randomized Controlled Trial
    Kelley, John M.
    Kaptchuk, Ted J.
    Cusin, Cristina
    Lipkin, Samuel
    Fava, Maurizio
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2012, 81 (05) : 312 - 314
  • [38] Randomized, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder
    DeMartinis, N.
    Yeung, P. P.
    Entsuah, R.
    Manley, A. L.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S233 - S234
  • [39] Evidence for Anti-inflammatory Effects of Adalimumab in Treatment of Patients With Major Depressive Disorder: A Pilot, Randomized, Controlled Trial
    Abbasian, Fatemeh
    Bagheri, Sayna
    Moradi, Kamyar
    Keykhaei, Mohammad
    Etemadi, Ali
    Shalbafan, Mohammadreza
    Shariati, Behnam
    Vaseghi, Salar
    Samsami, Farhane-Sadat
    Akhondzadeh, Shahin
    CLINICAL NEUROPHARMACOLOGY, 2022, 45 (05) : 128 - 134
  • [40] Major depressive disorder, serotonin transporter, and personality traits: Why patients use suboptimal decision-making strategies?
    Must, Anita
    Juhdsz, Anna
    Rimanoczy, Agnes
    Szabo, Zoltan
    Keri, Szabolcs
    Janka, Zoltan
    JOURNAL OF AFFECTIVE DISORDERS, 2007, 103 (1-3) : 273 - 276
12345